AVADEL PHARMACEUTICALS PLC Annual Return On Equity in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Avadel Pharmaceuticals Plc quarterly/annual Return On Equity history and growth rate from 2014 to 2023.
  • Avadel Pharmaceuticals Plc Return On Equity for the quarter ending June 30, 2024 was -123 %, a 84.7% increase year-over-year.
  • Avadel Pharmaceuticals Plc annual Return On Equity for 2023 was -212 %, a 93% increase from 2022.
  • Avadel Pharmaceuticals Plc annual Return On Equity for 2022 was -3K %, a 4099% decline from 2021.
  • Avadel Pharmaceuticals Plc annual Return On Equity for 2021 was -71.5 %, a 1493% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -212 +2.79K +93% Jan 1, 2023 Dec 31, 2023
2022 -3K -2.93K -4099% Jan 1, 2022 Dec 31, 2022
2021 -71.5 -76.6 -1493% Jan 1, 2021 Dec 31, 2021
2020 5.13 -154 -96.8% Jan 1, 2020 Dec 31, 2020
2019 159 +322 Jan 1, 2019 Dec 31, 2019
2018 -163 -249 -290% Jan 1, 2018 Dec 31, 2018
2017 85.9 +168 Jan 1, 2017 Dec 31, 2017
2016 -82.4 Jan 1, 2016 Dec 31, 2016
2014 -170 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.